Barrington lowered the firm’s price target on Stoneridge (SRI) to $16 from $20-$25 and keeps an Outperform rating on the shares. The company’s Q3 came in weaker than expected and 2024 guidance was reduced as market challenges continue, the analyst tells investors in a research note.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.